Created at Source Raw Value Validated value
Oct. 26, 2020, 8:37 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: case group 55 patients treat with intravenous vitamin c 1.5 gram 4 times a day and Hydroxychloroquine \u200e\u200e400 mg in the \u200efirst day and then 200 mg BID plus Atazanavir / Ritonavir 300/100\u200e daily 5 days. Every vitamin c vial content of 500 mg and is from Darou Pakhsh factory. The patients receive 3 vials slow infusion (1-2 hours) with normalsaline. Duration of treatment base of clinical response is 3-5 days. Renal function with BUN and CR monitor every other day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: control group 55 patients treat with Hydroxychloroquine \u200e\u200e400 mg in the \u200efirst day and then 200 mg BID plus Atazanavir / Ritonavir 300/100\u200e daily 5 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1369, "treatment_name": "Vitamin c", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]